arrow
C

Charlotte Suppli Ulrik

copenhagen university hospital - hvidovre
H指数:52
被引数:9,620

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Second-line dupilumab after anti-IL5/Rα failure: remission rates and clinical outcomes in severe asthma

二线度普利尤单抗在抗IL-5/Rα治疗失败后的应用:重症哮喘的缓解率和临床结局

2026-10-140
OAAI
Inhaled, nasal and topical corticosteroid burden and association with corticosteroid-associated adverse events

吸入、鼻用和局部皮质类固醇负担及其与皮质类固醇相关不良事件的关系

2026-10-100
OAAI
ARIA-EAACI 2025: Person-Centred, Digitally Enabled and Artificial Intelligence-Assisted Change Management in Airway Diseases

ARIA-EAACI 2025:气道疾病中以患者为中心、数字化赋能和人工智能辅助的变革管理

2026-09-030
OAAI
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study

易得生物制剂与重症哮喘缓解及其他临床结局的关联:一项全球真实世界研究

2026-08-060
OA
Long-term efficacy but rare sustained remission: individual-level 5-year stability in anti-IL5/Rα biologic therapy response for severe asthma
2026-03-010
PRE
Mortality in severe asthma: results from the NORDSTAR cohort

重症哮喘的死亡率——来自NORDSTAR队列的研究结果

2026-03-012
PRE
Identifying an At-Risk Asthma Phenotype: Allergy and Recurrent Infections Predict Severe Disease

识别高风险哮喘表型:过敏和反复感染预示严重疾病

2026-02-080
OAAI
Hyperglycemia and insulin use in patients with COVID-19 and severe hypoxemia allocated to 12 mg vs. 6 mg of dexamethasone: a secondary analysis of the COVID STEROID 2 randomized trial

高血糖和胰岛素使用在COVID-19合并严重低氧血症患者中分配接受12 mg与6 mg地塞米松的情况:COVID STEROID 2随机试验的二次分析

2025-07-150
OAAI
Effect of Telemonitoring on Moderate and Severe Exacerbations in Patients with COPD: Pooled Analysis of Two Randomized Controlled Trials in Denmark

远程监测对COPD患者中度和重度急性加重的影响:丹麦两项随机对照试验的合并分析

2025-07-110
OA
Prevalence; Change and Burden of Systemic Corticosteroid Use in Type 2 Inflammation Associated Diseases Over 25 Years – A Nationwide Danish Study

患病率;25年间系统性糖皮质激素在2型炎症相关疾病中的使用变化与负担——一项全国性丹麦研究

2025-06-060
OA
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

生物制剂启动对口服糖皮质激素使用的影响:国际重症哮喘注册登记研究与国际患者护理研究数据库的真实世界数据合并分析

2025-04-260
OAAI
The Predictive Role of C-Reactive Protein, Leukocyte Cell Count, and Soluble Urokinase Plasminogen Activator Receptor for Pulmonary Sequelae in Hospitalized COVID-19 Survivors: A Prospective Single-Center Cohort Study
2025-03-010
OAAI
Early Reduction of FeNO on Anti-IL5 Biologics Is Associated With Clinical Remission of Severe Asthma

早期降低Anti-IL5生物制剂的FeNO与严重哮喘的临床缓解有关

2024-12-140
PRE